Herpes Simplex Virus 1 & 2 Analysis
Use
This test provides analysis of herpes simplex virus (HSV) types 1 and 2 in amniotic fluid. Results should be interpreted in the context of relevant clinical and ultrasound information. It is specifically indicated for situations where a prenatal ultrasound reveals findings suggestive of an infectious pathogen. The detection of HSV-1 and HSV-2 is crucial in managing maternal and fetal health during pregnancy to avoid complications.
Special Instructions
Testing is indicated when prenatal ultrasound findings suggest the presence of an infectious pathogen. Results must be contextualized with clinical history and ultrasound data, ensuring that the testing provides added value in the decision-making process for patient management during pregnancy. Ordering providers should ensure that results are reviewed with patients appropriately, considering the implications of both positive and negative outcomes.
Limitations
This test is designed specifically to detect HSV types 1 and 2 in amniotic fluid. There may be limitations in detection if the sample is not collected properly or if the viral load is below the assay’s detection threshold. Clinical context and other laboratory findings should always be considered when interpreting results. False negatives may occur, particularly if the infection has not been established at the time of sampling.
Methodology
PCR-based (RT-PCR)
Biomarkers
Result Turnaround Time
5 days
Related Documents
For more information, please review the documents below
Specimen
Amniotic Fluid (Unknown)
Volume
1 mL
Minimum Volume
1 mL
Container
sterile leak-proof container
Collection Instructions
Collect 1 mL amniotic fluid in a sterile leak-proof container